Related Tags >> Generics India FDA Ranbaxy

patent News

Most Popular patent Story

Pfizer's future rests with biotech

September 13, 2007 — 11:00am ET | By Maureen Martino

At this week’s Bear Stearns Healthcare Conference, Pfizer discussed its plans for the future with analysts. As we all know, Pfizer is facing a major loss of sales when its best-selling drug... Read more...

patent Press Releases

ARIAD Announces Favorable Ruling Permitting Immediate Appeal of District Court Findings on NF-κB Patent in Amgen Litigation
Landmark study reports breakdown in biotech patent system
PRESS RELEASE: Teva Receives Favorable Court Decision Regarding Generic Famvir Tablets
PRESS RELEASE: Forest Laboratories Announces Federal Appeals Court Upholds Lexapro Patent Decision

Latest Headlines

Elan wins $55M judgment in patent scrap
June 16, 2008
Abraxis buys Shimoda, subsidiary
April 4, 2008
Scientists raise warnings over MS drug study risks
November 1, 2007
In new approach, R&D units are spun off
October 25, 2007
Pfizer's future rests with biotech
September 13, 2007
China now leads India in ongoing clinical trials
August 28, 2007
Patent rules create new biotech hazards
August 22, 2007
SPOTLIGHT: Does the patent cliff drive innovation?
August 10, 2007
Biovail inks deal for late-stage therapy
August 8, 2007
J&J restructures pharma unit, laying off workers
July 31, 2007
ALSO NOTED: CRO market hits $14B; Merck ends BioXell pact; and much more...
July 20, 2007
Dr. Reddy's make risky biogenerics move
June 29, 2007
Press Release: Bradley Pharmaceuticals Announces FDA Approval Of Elestrin
December 19, 2006
FDA wants more data on new Aranesp doses
October 15, 2006
Analysts raise doubts on Erbitux ruling
September 19, 2006
Biovail trading halted on generic court decision
August 1, 2006
Zocor feeling the heat from generics
July 16, 2006
SPOTLIGHT: Aradigm garners $27.5M in pact
July 4, 2006
Chinese companies dispute patent ruling
June 18, 2006
FDA backlog slows generic drug approval
April 9, 2006

Paid Research Reports